Log in to save to my catalogue

Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 si...

Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 si...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2495402266

Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling

About this item

Full title

Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling

Publisher

New York: Springer US

Journal title

Molecular and cellular biochemistry, 2021-06, Vol.476 (6), p.2551-2559

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

The continuous rise in relapse rate and mortality for multiple myeloma (MM) demands an effective treatment option. The microRNAs are emerging nowadays for their promising therapeutic potential. Earlier, we reported involvement of Versican (VCAN) in myeloma pathogenesis which could be inhibited by miR-144 and miR-199 in stroma. However, there is dea...

Alternative Titles

Full title

Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2495402266

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2495402266

Other Identifiers

ISSN

0300-8177

E-ISSN

1573-4919

DOI

10.1007/s11010-020-04038-5

How to access this item